Charles J Homcy's Net Worth

$74.6 Million

Estimate Recalculated Sep 17, 2024 05:46PM EST

Who is Charles J Homcy?

Charles J Homcy has an estimated net worth of $74.6 Million. This is based on reported shares across multiple companies, which include Population Health Investment Co., Inc., KOSAN BIOSCIENCES INC, PLIANT THERAPEUTICS, INC., GERON CORP, BridgeBio Pharma, Inc., Global Blood Therapeutics, Inc., CYTOKINETICS INC, MyoKardia Inc, CEPHALON INC, PORTOLA PHARMACEUTICALS INC, and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Charles J Homcy's CIK is 0001192591

Past Insider Trading and Trends

2007 was Charles J Homcy's most active year for acquiring shares with 15 total transactions. Charles J Homcy's most active month to acquire stocks was the month of April. 2008 was Charles J Homcy's most active year for disposing of shares, totalling 25 transactions. Charles J Homcy's most active month to dispose stocks was the month of April. 2021 saw Charles J Homcy paying a total of $10,781,250.00 for 151,838 shares, this is the most they've acquired in one year. In 2017 Charles J Homcy cashed out on 561,606 shares for a total of $14,436,327.44, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Population Health Investment Co., Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 26
Form 3
—
0
—
—
0
No matching records found

KOSAN BIOSCIENCES INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 27
No matching records found

PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $12.87

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 29
Form 3
—
0
—
—
0
No matching records found

GERON CORP (GERN) Snapshot price: $4.29

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-45.55%
-52.50K
—
—
62.75K
May 11
Form 4
+64.06%
45K
—
—
115.25K
Jul 9
Form 4
+7.66%
5K
—
—
70.25K
May 19
Form 4
+75.48%
28.07K
$6.52
$19,996.84
65.25K
May 29
Form 4
+36.98%
10.04K
—
—
37.18K
May 28
Form 4
+35.73%
7.15K
—
—
27.15K
May 23
Form 4
∞
20K
—
—
20K
Jan 3
Form 4
—
0
—
—
0
May 24
Form 3
—
0
—
—
0
No matching records found

BridgeBio Pharma, Inc. (BBIO) Snapshot price: $30.7

Chairman Pharmaceuticals

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
+0.18%
2.25K
$37.21
-$56,149.89
1.23M
Feb 16
Form 4
+0.20%
2.46K
$28.86
-$37,546.86
1.23M
Nov 16
Form 4
+0.20%
2.46K
$29.80
-$38,769.80
1.22M
Aug 16
Form 4
—
0
—
—
0
Jun 21
Form 4
+0.20%
2.46K
$14.09
-$18,317.00
1.22M
May 16
Form 4
+0.18%
2.23K
$12.64
-$19,389.76
1.22M
Feb 16
Form 4
+0.20%
2.46K
$9.64
-$12,541.64
1.21M
Nov 16
Form 4
+0.20%
2.47K
$11.08
-$14,259.96
1.21M
Aug 16
Form 4
—
0
—
—
0
Jun 22
Form 4
+0.18%
2.22K
$6.74
-$10,386.34
1.21M
May 16
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Dec 2
Form 4
—
0
—
—
0
Jun 17
Form 4
+0.08%
1K
$71.91
-$37,680.84
1.2M
Mar 1
Form 4
—
0
$29.00
-$246,144.00
1.2M
Scheduled
Oct 16
Form 4
—
0
$27.50
-$210,000.00
1.2M
Scheduled
Sep 30
Form 4
-7.62%
-99.26K
$36.95
-$3,667,954.96
1.2M
Scheduled
Sep 25 - Sep 29
Form 4
—
0
—
—
0
Jun 2
Form 4
-2.98%
-40.00K
—
—
1.3M
Apr 3
Form 4
-1.47%
-20.00K
$36.00
-$720,000.00
1.34M
Scheduled
Feb 10
Form 4
—
0
$26.00
-$180,000.00
1.36M
Scheduled
Jan 14
Form 4
—
0
—
—
0
Dec 12
Form 4
∞
1.36M
—
—
1.36M
Jul 1
Form 3
—
0
—
—
0
No matching records found